-
Mashup Score: 3Regulatory News for April 24, 2024 - ILCN.org (ILCN/WCLC) - 4 day(s) ago
US FDA grants accelerated approval of HER2-targeting antibody drug conjugate; China accepts supplemental new drug application for savolitinib.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14Can Artificial Intelligence Identify Those at High Risk and Shift the Lung Cancer Screening Paradigm? - ILCN.org (ILCN/WCLC) - 8 day(s) ago
In a recent interview, Dr. Lecia V. Sequist, a member of the team behind the Sybil AI algorithm, discusses how technology may soon be able to predict who will develop lung cancer.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy - ILCN.org (ILCN/WCLC) - 11 day(s) ago
Drs. Christi M.J. Steendam and Sushil K. Badrising review studies comparing outcomes of various treatment regimens in the search for the best-performing approach.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion - ILCN.org (ILCN/WCLC) - 22 day(s) ago
The association seeks input from members to better understand the current DEI landscape so it can continue to build a diverse international community dedicated to the elimination of thoracic malignancies.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5US Food and Drug Administration Accepts New Drug Application for Ensartinib - ILCN.org (ILCN/WCLC) - 23 day(s) ago
The filing was based on results from a global phase III study designed to compare the ALK inhibitor to crizotinib in the first-line treatment of ALK-positive NSCLC.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3The Promise of Artificial Intelligence-Aided Pathology in Thoracic Oncology - ILCN.org (ILCN/WCLC) - 24 day(s) ago
Profs. Jan von der Thüsen and John Le Quesne say while still in the early phases, AI has the potential to bring accessible and affordable prognosis and response prediction tools to all.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 18
Drs. Matthew Lee, Benjamin Levy, and Balazs Halmos say several key issues need to be addressed before this class of agents can achieve wider impact.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 18
Drs. Matthew Lee, Benjamin Levy, and Balazs Halmos say several key issues need to be addressed before this class of agents can achieve wider impact.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR - ILCN.org (ILCN/WCLC) - 1 month(s) ago
The move was supported by preliminary evidence from a phase I, first-in-human study in patients with advanced NSCLC.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7Regulating Artificial Intelligence - ILCN.org (ILCN/WCLC) - 1 month(s) ago
The US FDA’s Dr. Harpreet Singh talks with ILCN about what the increasing use of AI means for the agency as it works to ensure drugs and devices are safe and effective.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
Stay on top of regulatory news with #ILCN, including @FDAOncology accelerated approval of T-DXd for unresectable or metastatic HER2-positive solid tumors. https://t.co/9HKMgDVBa7 #LCSM